14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £1.50 £1.70 Friday, 3rd May 2024 HEMO.L stock ended at £1.57. This is 0.128% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.16% from a day low at £1.53 to a day high of £1.62.
90 days £1.50 £7.13
52 weeks £1.10 £7.13

Historical Hemogenyx Pharmaceuticals Plc prices

Date Open High Low Close Volume
May 03, 2024 £1.54 £1.62 £1.53 £1.57 6 130 744
May 02, 2024 £1.62 £1.62 £1.54 £1.57 4 835 398
May 01, 2024 £1.56 £1.60 £1.53 £1.57 1 222 010
Apr 30, 2024 £1.56 £1.58 £1.50 £1.56 3 646 685
Apr 29, 2024 £1.69 £1.69 £1.55 £1.55 10 976 230
Apr 26, 2024 £1.60 £1.68 £1.60 £1.65 1 887 734
Apr 25, 2024 £1.62 £1.70 £1.53 £1.60 5 559 021
Apr 24, 2024 £1.70 £1.70 £1.58 £1.61 5 125 269
Apr 23, 2024 £1.62 £1.70 £1.60 £1.63 4 149 413
Apr 22, 2024 £1.62 £1.70 £1.60 £1.62 5 660 453
Apr 19, 2024 £1.67 £1.67 £1.59 £1.64 5 990 463
Apr 18, 2024 £1.64 £1.69 £1.60 £1.67 13 610 160
Apr 17, 2024 £1.61 £1.65 £1.55 £1.60 4 373 338
Apr 16, 2024 £1.62 £1.65 £1.58 £1.60 3 322 585
Apr 15, 2024 £1.58 £1.65 £1.58 £1.60 3 285 653
Apr 12, 2024 £1.56 £1.65 £1.55 £1.62 4 211 920
Apr 11, 2024 £1.62 £1.65 £1.58 £1.61 3 130 169
Apr 10, 2024 £1.56 £1.63 £1.55 £1.61 6 398 600
Apr 09, 2024 £1.60 £1.70 £1.55 £1.60 13 607 003
Apr 08, 2024 £1.64 £1.70 £1.58 £1.62 33 278 593
Apr 05, 2024 £1.59 £1.70 £1.59 £1.63 16 427 606
Apr 04, 2024 £1.60 £1.65 £1.57 £1.61 7 303 593
Apr 03, 2024 £1.68 £1.68 £1.56 £1.62 10 364 121
Apr 02, 2024 £1.76 £1.76 £1.76 £1.76 0
Mar 28, 2024 £1.74 £1.80 £1.72 £1.76 8 122 292
Click to get the best stock tips daily for free!

About Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic ... HEMO.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT